Home › Funds › RA CAPITAL MANAGEMENT, L.P. › ABVX
RA CAPITAL MANAGEMENT, L.P. position in ABVX
ABIVAX SA · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 1,030,058 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$102.0M, representing 1.05% of its reported portfolio and ranking #21 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed ABVX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s ABVX position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in ABVX in Q2 2026 at 1,132,557 shares (US$150.9M). Across 2 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,030,058 shares valued at US$102.0M — a reduction of -102,499 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.13M | $150.92M | New |
| Q3 2026 | 1.03M | $102.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 57 other funds we track also report a position in ABVX — the largest reported positions include Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$398.2M), Vestal Point Capital, LP (US$392.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- Helikon Investments Ltd 4.22M sh · $418.15M · Q3 2026
- Darwin Global Management, Ltd. 4.02M sh · $398.22M · Q3 2026
- Vestal Point Capital, LP 3.96M sh · $392.12M · Q3 2026
- TCG Crossover Management, LLC 3.66M sh · $362.71M · Q3 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M sh · $163.56M · Q3 2026
- Caligan Partners LP 1.56M sh · $154.27M · Q3 2026
- Eversept Partners, LP 1.10M sh · $108.99M · Q3 2026
- Octagon Capital Advisors LP 993.00K sh · $98.33M · Q3 2026
- Logos Global Management LP 870.00K sh · $86.15M · Q3 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 762.82K sh · $75.53M · Q3 2026
- Two Seas Capital LP 676.59K sh · $67.00M · Q3 2026
- Saturn V Capital Management LP 529.31K sh · $52.41M · Q3 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held ABVX?
RA CAPITAL MANAGEMENT, L.P. has disclosed ABVX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in ABVX?
As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 1.03M shares of ABVX (ABIVAX SA), valued at $102.00M, representing 1.05% of its reported portfolio and ranking #21.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling ABVX?
In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in ABVX.
Which other funds hold ABVX?
Other major institutional holders of ABVX include Helikon Investments Ltd, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.